×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Instil Bio Inc. (TIL) NASDAQ

$11.04 (0.20) (-1.82%)

Market Cap: $71.77M

As of 05/24/24 04:00 PM EDT. Market closed.

(TIL)

Instil Bio Inc. (TIL)
NASDAQ

$11.04
(0.20) (-1.82%)

Market Cap: $71.77M

As of 05/24/24 04:00 PM EDT. Market closed.

Add to Portfolio

instil bio is a cell therapy company developing tumor infiltrating lymphocytes (til) for the treatment of solid tumor cancers. til are a patient’s own t cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. the company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Bronson Crouch
Full Time Employees
335
URL
Address
3963 Maple Avenue, Suite 350, TX, Dallas, 75219.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Bronson Crouch
Full Time Employees
335
Address
3963 Maple Avenue, Suite 350, TX, Dallas, 75219.
PRICE CHART FOR INSTIL BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$11.01
Previous Close
$11.24
Days Range
$10.80 - $11.21
52 week range
$6.07 - $12.98
Volume
13,480
Avg. Volume (30 days)
10,332
Market Cap
$71.77M
Dividend Yield
-
P/E
-
Shares Outstanding
6,503,913
Open
$11.01
Previous Close
$11.24
Days Range
$10.80 - $11.21
52 week range
$6.07 - $12.98
Volume
13,480
Avg. Volume (30 days)
10,332
Market Cap
$71.77M
Dividend Yield
-
P/E
-
Shares Outstanding
6,503,913
FINANCIAL STATEMENTS FOR INSTIL BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INSTIL BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Vivo Capital IX, LLC10% OwnerMar 23, 2021 Buy$20.00300,0006,000,00012,486,787Mar 25, 2021, 05:32 PM
Shah Nimish PDirectorMar 23, 2021 Buy$20.00300,0006,000,0005,635,937Mar 25, 2021, 05:31 PM
Nielsen JackDirectorMar 23, 2021 Buy$20.00300,0006,000,00012,486,787Mar 25, 2021, 05:30 PM
McGaughy R Kent JrDirectorMar 23, 2021 Buy$20.00450,0009,000,0008,478,790Mar 25, 2021, 05:28 PM
Curative Ventures V LLC10% OwnerMar 23, 2021 Buy$20.00450,0009,000,00037,980,073Mar 25, 2021, 04:29 PM
Crouch BronsonCEO and ChairmanMar 23, 2021 Buy$20.00450,0009,000,00037,980,073Mar 25, 2021, 04:27 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Vivo Capital IX, LLC10% Owner03/23/20216,000,000
Shah Nimish PDirector03/23/20216,000,000
Nielsen JackDirector03/23/20216,000,000
McGaughy R Kent JrDirector03/23/20219,000,000
Curative Ventures V LLC10% Owner03/23/20219,000,000
Crouch BronsonCEO and Chairman03/23/20219,000,000
FUNDS WITH A POSITION IN INSTIL BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC624,3380.53%-0.00032%Other
RENAISSANCE TECHNOLOGIES LLC126,2550.00214%11.13%Other
BLACKROCK INC.61,0190.00002%62.28%Other
GEODE CAPITAL MANAGEMENT, LLC34,7520.00003%10.58%Other
CHANGE IN SHARES OUTSTANDING FOR INSTIL BIO INC
STOCK BUYBACKS FOR INSTIL BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
03/31/2021
-81.41%
11Q
12/31/2023
09/30/2020
-61.58%
13Q
12/31/2023
06/30/2020
-61.39%
14Q
12/31/2023
03/31/2020
-49.96%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
-81.41%
11Q
09/30/2020
-61.58%
13Q
06/30/2020
-61.39%
14Q
03/31/2020
-49.96%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INSTIL BIO INC
LOADING...